Neurothrombectomy Devices Market Analysis

Neurothrombectomy Devices Market Analysis

To get key market trends

  Download Free Sample

The stent retrievers segment was worth USD 378 million in 2023. Its ascendancy is attributed to their exceptional efficacy in treating ischemic stroke.
 

• Stent retrievers renowned for their high success rates in mechanically removing blood clots. These devices swiftly restore blood flow in affected vessels, leading to improved patient outcomes.
   
• Moreover, extensive clinical validation, versatility in addressing various clot sizes, and continuous technological advancements contribute to their dominance.
   
• Furthermore, medical guidelines endorsing stent retrievers as a standard of care, coupled with positive physician experiences and superior patient outcomes, solidifies their preference in the neurothrombectomy landscape.

Based on end-use, the hospitals and clinics segment garnered USD 463 million revenue in 2023.
 

• Hospitals and clinics take the lead in the neurothrombectomy devices market due to their centralized infrastructure, specialized expertise, and advanced imaging capabilities.
   
• These institutions provide a collaborative care environment, crucial for intricate neurothrombectomy procedures. Equipped with emergency services, post-procedure care infrastructure, and a commitment to regulatory standards, hospitals and clinics are well-positioned to address complex neurological conditions effectively.

U.S. neurothrombectomy devices market size surpassed USD 244 million in 2023 and is predicted to witness substantial market growth.
 

• The U.S. commands a leading position in the neurothrombectomy devices industry, stimulated by its advanced healthcare infrastructure, robust research and development landscape, and a high incidence of ischemic stroke.
   
• For instance, according to estimates from the Centers of Disease Control and Prevention, ischemic stroke accounts for around 87% of all strokes in the U.S., with 75% of cases occurring in individuals experiencing their first stroke. Annually, almost 800,000 Americans suffer from a stroke, ranking it as the fifth leading cause of death, with a mortality rate of 45.2 per 100,000 population.
   
• Thus, the country's strong emphasis on research and development, coupled with a high prevalence of ischemic strokes, fuels continuous advancements and widespread use of these devices.
   
• Furthermore, the presence of leading medical device manufacturers and a proactive approach to neurological healthcare further solidify the U.S.'s dominance in the market.